Mutations in the MTERF1 DNA-binding sequence lead to a spectrum of diseases under the syndrome MELAS (mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes) with devastating neuromuscular consequences. This evidence concerns the gene MTERF1 and MELAS.